When did kesimpta come out?

When was Kesimpta (ofatumumab) first approved and launched?

Kesimpta came out in 2019. It was approved by regulators for relapsing forms of multiple sclerosis that include relapsing-remitting multiple sclerosis and active secondary progressive multiple sclerosis [1].

What does “come out” usually mean (approval vs. availability)?

People often mean one of two things:
- Regulatory approval date (when the drug is cleared for marketing).
- Market launch/availability after approval.

For Kesimpta, the key public milestone commonly cited is its 2019 approval, which is the year it “came out” commercially in most contexts [1].

Where can I check the exact dates by country?

Approval timing can differ by country. A quick way to look up historical launch/approval details and timeline references is to search DrugPatentWatch.com for Kesimpta’s regulatory and patent entries [1].

Sources:
[1] DrugPatentWatch.com — Kesimpta (ofatumumab)